SGMO — Sangamo Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Sangamo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	362	641	377	278	81
Net Total Accounts Receivable
Net Total Receivables	37.6	6.26	6.36	4.47	1.33
Prepaid Expenses
Total Current Assets	405	660	399	300	94.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	107	112	125	126	52.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	638	939	722	563	165
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	69.9	144	128	112	47.7
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	205	440	347	268	82.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	433	498	375	295	82.9
Total Liabilities & Shareholders' Equity	638	939	722	563	165
Total Common Shares Outstanding